S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: Tiny biotech successfully treats blindness (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
BREAKING: Tiny biotech successfully treats blindness (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: Tiny biotech successfully treats blindness (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
BREAKING: Tiny biotech successfully treats blindness (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: Tiny biotech successfully treats blindness (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
BREAKING: Tiny biotech successfully treats blindness (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: Tiny biotech successfully treats blindness (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
BREAKING: Tiny biotech successfully treats blindness (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
TSE:MBX

Microbix Biosystems (MBX) Stock Forecast, Price & News

C$0.40
0.00 (0.00%)
(As of 05/26/2023 08:49 PM ET)
Compare
Today's Range
C$0.40
C$0.40
50-Day Range
C$0.35
C$0.42
52-Week Range
C$0.30
C$0.57
Volume
500 shs
Average Volume
46,446 shs
Market Capitalization
C$55.38 million
P/E Ratio
34.00
Dividend Yield
N/A
Price Target
N/A

MBX stock logo

About Microbix Biosystems (TSE:MBX) Stock

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Get MarketBeat All Access Free for 30 Days
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Try it free for 30 days.
Microbix Announces Extension of Warrant Expiry Date
Microbix Biosystems (TSE:MBX) Shares Up 12%
Dually-Listed Biotech Shares Up Big On Tuesday
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Microbix Reports Results for Q2 Fiscal 2023
Governments of Ontario and Canada Invest in Microbix
Microbix Launches QAP to Support “Monkeypox” Testing
Microbix Reports Record Sales for Fiscal 2022
Microbix Announces Initiation of Normal Course Issuer Bid
See More Headlines
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Company Calendar

Today
5/29/2023
Next Earnings (Estimated)
8/10/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$16.72 million
Cash Flow
C$0.10 per share
Book Value
C$0.18 per share

Miscellaneous

Free Float
N/A
Market Cap
C$55.38 million
Optionable
Not Optionable
Beta
0.14

Key Executives

  • Mr. Cameron L. Groome
    Pres, CEO & Director
  • Mr. James S. Currie
    Chief Financial Officer
  • Dr. Kenneth Hughes Ph.D.
    Chief Operating Officer
  • Dr. Mark Luscher Ph.D.
    Sr. VP of Scientific Affairs
  • Mr. Philip Casselli
    Sr. VP of Sales, Bus. Devel. & Marketing
  • Mr. Christopher B. Lobb
    Compliance Officer, Gen. Counsel & Sec.













MBX Stock - Frequently Asked Questions

Should I buy or sell Microbix Biosystems stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBX shares.
View MBX analyst ratings
or view top-rated stocks.

How have MBX shares performed in 2023?

Microbix Biosystems' stock was trading at C$0.41 at the start of the year. Since then, MBX shares have decreased by 2.4% and is now trading at C$0.40.
View the best growth stocks for 2023 here
.

When is Microbix Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our MBX earnings forecast
.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).

What is Microbix Biosystems' stock symbol?

Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX."

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Microbix Biosystems' stock price today?

One share of MBX stock can currently be purchased for approximately C$0.40.

How much money does Microbix Biosystems make?

Microbix Biosystems (TSE:MBX) has a market capitalization of C$55.38 million and generates C$16.72 million in revenue each year.

How can I contact Microbix Biosystems?

Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The official website for the company is microbix.com. The company can be reached via phone at +1-905-3618910.

This page (TSE:MBX) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -